TRiCares Receives FDA Approval for TRICURE US IDE Pivotal Trial with the Topaz Tricuspid Valve Replacement System

AI Briefing

• – TRiCares receives FDA approval for IDE for Topaz TTVR system.
• – The approval allows for pivotal clinical trial in US, Canada, and select European sites.
• – TRiCares aims to treat tricuspid regurgitation with minimally invasive treatment.